have pioneered a dual-responsive lactoferrin nanostructured microsphere that responds to both temperature and pH, establishing a promising oral targeted delivery system for CRC that significantly improved targeting and therapeutic effects in the intestinal environment (45). Here, LTF is linked to colorectal carcinoma.